UIC's New Cancer Energy Attack
University of Illinois Chicago researchers have developed a groundbreaking cancer treatment that starves tumor cells by inhibiting their energy production with a bacteria-derived peptide called aurB. This innovative therapy demonstrated significant tumor growth inhibition in preclinical prostate cancer models, including resistant types, and is now poised for human clinical trials.